Genting and TauRx applying for UK, US regulators' approval for Alzheimer's drug

KUALA LUMPUR: Genting Bhd, along with its partner TauRx Pharmaceuticals Ltd., is currently seeking approval from both the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) and the US Food and Drug Administration (FDA) for its Alzheimer's disease drug.

© New Straits Times Press (M) Bhd